Abstract:Background: Obstructive sleep apnoea is the periodic reduction (hypopnoea) or cessation (apnoea) of breathing due to narrowing or occlusion of the upper airway during sleep. The main symptom is daytime sleepiness and it has been suggested it is linked to premature death, hypertension, ischaemic heart disease, stroke and road traffic accidents. Objectives: The main treatment for sleep apnoea is with the use of continuous positive airways pressure (CPAP), which requires a flow generator and mask. These are used at night to prevent apnoea, hypoxia and sleep disturbance. The objective was to assess the effects of CPAP in the treatment of obstructive sleep apnoea in adults. Search strategy: We searched the Cochrane Airways Group Trials Register and reference lists of articles. We consulted experts in the field. Searches were current to July 2005. Selection criteria: We included randomised trials comparing nocturnal CPAP with an inactive control or oral appliances in adults with obstructive sleep apnoea (an apnoea and hypopnoea index greater than five per hour). Trials had a minimum intervention period of two weeks. Data collection and analysis: Trial quality was assessed and two review authors extracted data independently. Study authors were contacted for missing information. Parallel and crossover group trials were analysed separately. Main results: Thirty-six trials involving 1718 people met the inclusion criteria. Study quality was mixed. Compared with control, CPAP showed significant improvements in objective and subjective sleepiness and several quality of life, cognitive function and depression measures (parallel-group studies: Epworth sleepiness scale (ESS) -3.83 units, 95% CI -4.57 to -3.09; crossover studies: ESS -1.84 units, 95% CI -2.57 to -1.11). Twenty-four hour systolic and diastolic blood pressures were lower with CPAP compared with control (parallel-group trials). Compared with oral appliances, CPAP significantly reduced the apnoea and hypopnoea index (crossover studies: -7.97 events/hr, 95% CI -9.56 to -6.38) and improved sleep efficiency (crossover studies: 2.31%, 95% CI 0.02 to 4.6) and minimum oxygen saturation (4.14%, 95% CI 3.25 to 5.03). Responders to both treatments expressed a strong preference for the oral appliance. However, participants were more likely to withdraw on OA than on CPAP therapy. Authors' conclusions: CPAP is effective in reducing symptoms of sleepiness and improving quality of life measures in people with moderate and severe obstructive sleep apnoea (OSA). It is more effective than oral appliances in reducing respiratory disturbances in these people but subjective outcomes are more equivocal. Certain people tend to prefer oral appliances to CPAP where both are effective. This could be because they offer a more convenient way of controlling OSA. Short-term data indicate that CPAP leads to lower blood pressure than in controls. Long-term data are required for all outcomes in order to determine whether the initial benefits seen in short-term clinical trials persist.

A randomized controlled trial on ambulatory blood pressure lowering effect of CPAP in patients with obstructive sleep apnea and nocturnal hypertension

Continuous positive airway pressure adherence and blood pressure lowering in patients with obstructive sleep apnoea syndrome and nocturnal hypertension

Beneficial Response of Blood Pressure to Short-Term Continuous Positive Airway Pressure in Chinese Patients with Obstructive Sleep Apnea-Hypopnea Syndrome.

Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients

Mandibular advancement device versus CPAP in lowering 24-hour blood pressure in patients with obstructive sleep apnoea and hypertension: the CRESCENT trial protocol

Meta-analysis: the efficacy of continuous positive airway pressure therapy on blood pressure in obstructive sleep apnea hypopnea syndrom patients

Analysis of the improvement of quality of life in patients with obstructive sleep apnea hypopnea syndromes associated hypertension with continuous positive airway pressure

Elevated Nocturnal and Morning Blood Pressure in Patients with Obstructive Sleep Apnea Syndrome

Study on 24H-Blood Pressure Variability in Patients of Obstructive Sleep Apnea with Continuous Positive Airway Pressure Therapy

CPAP effects on blood pressure in different OSA phenotypes - a meta-analysis

Effects of short-term continuous positive airway pressure treatment on arterial stiffness in patients with obstructive sleep apnea hypopnea syndrome]

[Effects of Oral Appliance Treatment Upon Blood Pressure in Mild to Moderate Obstructive Sleep Apnea-Hypopnea Syndrome].

Effect of Continuous Positive Airway Pressure on Blood Pressure in Patients with Resistant Hypertension and Obstructive Sleep Apnea: An Updated Meta-analysis

Continuous positive airways pressure for obstructive sleep apnoea

Obstructive sleep apnea and ambulatory blood pressure monitoring: current evidence and research gaps

Continuous positive airways pressure for obstructive sleep apnoea in adults

Predictors of blood pressure response to continuous positive airway pressure treatment in patients with sleep apnea

Treatment with Continuous Positive Airway Pressure Is Not Effective in Patients with Sleep Apnea but No Daytime Sleepiness

Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea

Continuous Positive Airway Pressure Treatment for Functional Cardiac Arrhythmias Combined with Obstructive Sleep Apnea Hypopnea Syndrome